Arno Therapeutics, Inc. (OTCMKTS:ARNI – Get Free Report)’s stock price passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.00 and traded as high as $0.00. Arno Therapeutics shares last traded at $0.00, with a volume of 0 shares trading hands.
Arno Therapeutics Trading Down 100.0%
About Arno Therapeutics
Arno Therapeutics, Inc, a biopharmaceutical company, develops products for the treatment of cancer and other life threatening diseases. The company’s product development pipeline includes Onapristone, a type 1 anti-progestin hormone blocker that is in Phase I/II clinical study for the treatment of breast, endometrial, and others solid tumors in post-menopausal women; and advanced castration-resistant prostate cancer in men.
See Also
- Five stocks we like better than Arno Therapeutics
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Nextracker’s Solar Surge: Will It Shatter Its All-Time High?
- How to Use Stock Screeners to Find Stocks
- Savvy Investors Are Raising a Glass for Heineken Stock
- Most Volatile Stocks, What Investors Need to Know
- Top 4 ETFs for China Exposure After Tariff Relief
Receive News & Ratings for Arno Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arno Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
